Amphastar Pharmaceuticals trades at a deep discount—6.7x trailing earnings—reflecting structural growth and margin challenges. Branded product growth (BAQSIMI, Primatene MIST) has not offset ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. MannKind’s fair value ...

Changes in net revenues as compared to the first quarter of the prior year were primarily driven by: BAQSIMI ® sales decreased primarily due to a lower average selling price, as a result of a change ...

Management revealed plans to file and launch a proprietary soft mist inhaler, "Tresmi," which reduces inhaler-related cough by up to 90% based on conducted human studies. New cartridge and dosing ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Amphastar is a biopharmaceutical company that focuses on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products.

BASTROP COUNTY, Texas — A family is demanding answers after a worker died in an incident at a Bastrop County factory. Occupational Safety and Health Administration (OSHA) officials confirm they are ...

FDA clearance positions budesonide/glycopyrrolate/formoterol as the sole US single-inhaler triple therapy for asthma in patients aged ≥12 years. Replicate KALOS ...

From asthma to COPD, inhalers are central to keeping symptoms under control—but choosing one involves more than convenience. Updated guidelines and research now factor in patient-specific health data, ...